[1] Hermann T, Patel DJ. Adaptive recognition by nucleic acid aptamers[J]. Science, 2000, 287(5454):820-825. [2] Tan LH,Neoh KG, Kang ET, et al. PEGylated anti-MUC1 aptamer-doxorubicin complex for targeted drug delivery to MCF7 breast cancer cells[J]. Macromol Biosci, 2011, 11(10):1331-1335. [3] Li XQ, Zhang P, Dou LQ,et al. Detection of circulating tumor cells in breast cancer patients by nanopore sensing with aptamer-mediated amplification[J]. ACS Sensor, 2020, 5(8):2359-2366. [4] Kolovskaya OS, Zamay TN, Belyanina IV, et al. Aptamer-targeted plasmonic photothermal therapy of cancer[J]. Mol Ther Nucleic Acids, 2017, 9:12-21. [5] Cech TR, Zaug AJ, Grabowski PJ. In vitro splicing of the ribosomal RNA precursor of Tetrahymena:Involvement of a guanosine nucleotide in the excision of the intervening sequence[J]. Cell, 1981, 27(3 Pt 2):487-496. [6] Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment:RNA ligands to bacteriophage T4 DNA polymerase[J]. Science, 1990, 249(4968):505-510. [7] Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands[J]. Nature, 1990, 346(6287):818-822. [8] 叶华. 脂多糖广谱型核酸适配体的定向筛选、序列优化及分析应用[D]. 无锡:江南大学, 2019. [9] 陈小波. CELL-SELEX基础上PANC-1核酸适配体的筛选[D]. 苏州:苏州大学, 2018. [10] 韩小东, 符兆英, 郭姝彤, 等. 核酸适配体筛选方法研究进展[J]. 陕西医学杂志, 2018, 47(3):407-409. [11] Zhang Y, Lai BS, Juhas M. Recent advances in aptamer discovery and applications[J]. Molecules, 2019, 24(5):E941. [12] Ahmadyousefi Y, Malih S, Mirzaee Y,et al. Nucleic acid aptamers in diagnosis of colorectal cancer[J]. Biochimie, 2019, 156:1-11. [13] Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration[J]. Retina, 2002, 22(2):143-152. [14] Ireson CR, Kelland LR. Discovery and development of anticancer aptamers[J]. Mol Cancer Ther, 2006, 5(12):2957-2962. [15] Cui W, Liu JJ,Su DH, et al. Identification of ssDNA aptamers specific to clinical isolates of Streptococcus mutans strains with different cariogenicity[J]. Acta Biochim Biophys Sin (Shanghai), 2016, 48(6):563-572. [16] 丁一. 牙周炎唾液检测标记物及应用前景[J]. 口腔医学, 2017, 37(11):961-964,1001. [17] Kestler DP, Foster JS, Macy SD, et al. Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms[J]. Mol Med, 2008, 14(5/6):318-326. [18] Lee BH, Kim SH, Ko Y, et al. The sensitive detection of ODAM by using sandwich-type biosensors with a cognate pair of aptamers for the early diagnosis of periodontal disease[J]. Biosens Bioelectron, 2019, 126:122-128. [19] Malathi L,Masthan KM, Balachander N, et al. Estimation of salivary amylase in diabetic patients and saliva as a diagnostic tool in early diabetic patients[J]. J Clin Diagn Res, 2013, 7(11):2634-2636. [20] García-Berrocoso T, Giralt D, Bustamante A, et al. Role of beta-defensin 2 and interleukin-4 receptor as stroke outcome biomarkers[J]. J Neurochem, 2014, 129(3):463-472. [21] Minagawa H, Onodera K, Fujita H,et al. Selection, characterization and application of artificial DNA aptamer containing appended bases with sub-nanomolar affinity for a salivary biomarker[J]. Sci Rep, 2017, 7:42716. [22] Minagawa H, Kataoka Y, Kuwahara M,et al. A high affinity modified DNA aptamer containing base-appended bases for human β-defensin[J]. Anal Biochem, 2020, 594:113627. [23] Zou MJ, Chen Y, Xu X,et al. The homogeneous fluorescence anisotropic sensing of salivary lysozyme using the 6-carboxyfluorescein-labeled DNA aptamer[J]. Biosens Bioelectron, 2012, 32(1):148-154. [24] Ojha YR, Giovannucci DR, Cameron BD. Selection and characterization of structure-switching DNA aptamers for the salivary peptide histatin 3[J]. J Biotechnol, 2021, 327:9-17. [25] Sun JL, Yan JF, Yu SB, et al. MicroRNA-29b promotes subchondral bone loss in TMJ osteoarthritis[J]. J Dent Res, 2020, 99(13):1469-1477. [26] Li Z, Fu XK, Huang J,et al. Advances in screening and development of therapeutic aptamers against cancer cells[J]. Front Cell Dev Biol, 2021, 9:662791. [27] Simmons SC, Jämsä H, Silva D, et al. Anti-heparanase aptamers as potential diagnostic and therapeutic agents for oral cancer[J]. PLoS One, 2014, 9(10):e96846. [28] Sathiyaseelan A, Saravanakumar K,Mariadoss AVA, et al. pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment[J]. Carbohydr Polym, 2021, 262:117907. [29] Son J, Kim J, Lee K,et al. DNA aptamer immobilized hydroxyapatite for enhancing angiogenesis and bone regeneration[J]. Acta Biomater, 2019, 99:469-478. [30] Ardjomandi N, Niederlaender J,Aicher WK, et al. Identification of an aptamer binding to human osteogenic-induced progenitor cells[J]. Nucleic Acid Ther, 2013, 23(1):44-61. [31] Ardjomandi N, Huth J,Stamov DR, et al. Surface biofunctionalization of β-TCP blocks using aptamer 74 for bone tissue engineering[J]. Mater Sci Eng C Mater Biol Appl, 2016, 67:267-275. [32] Wang M, Wu H, Li Q, et al. Novel aptamer-functionalized nanoparticles enhances bone defect repair by improving stem cell recruitment[J]. Int J Nanomedicine, 2019, 14:8707-8724. [33] Hu XX, Wang YL, Tan YN, et al. A difunctional regeneration scaffold for knee repair based on aptamer-directed cell recruitment[J]. Adv Mater, 2017, 29(15):201605235. |